Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine.
MacMillen Z, Hatzakis K, Simpson A, Shears MJ, Watson F, Erasmus JH, Khandhar AP, Wilder B, Murphy SC, Reed SG, Davie JW, Avril M. MacMillen Z, et al. Among authors: wilder b. bioRxiv [Preprint]. 2023 May 23:2023.05.23.541932. doi: 10.1101/2023.05.23.541932. bioRxiv. 2023. Update in: NPJ Vaccines. 2024 Jan 10;9(1):12. doi: 10.1038/s41541-023-00799-4 PMID: 37292739 Free PMC article. Updated. Preprint.
Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies.
Wilder BK, Vigdorovich V, Carbonetti S, Minkah N, Hertoghs N, Raappana A, Cardamone H, Oliver BG, Trakhimets O, Kumar S, Dambrauskas N, Arredondo SA, Camargo N, Seilie AM, Murphy SC, Kappe SHI, Sather DN. Wilder BK, et al. NPJ Vaccines. 2022 May 26;7(1):58. doi: 10.1038/s41541-022-00480-2. NPJ Vaccines. 2022. PMID: 35618791 Free PMC article.
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver.
Franke-Fayard B, Marin-Mogollon C, Geurten FJA, Chevalley-Maurel S, Ramesar J, Kroeze H, Baalbergen E, Wessels E, Baron L, Soulard V, Martinson T, Aleshnick M, Huijs ATG, Subudhi AK, Miyazaki Y, Othman AS, Kolli SK, Lamers OAC, Roques M, Stanway RR, Murphy SC, Foquet L, Moita D, Mendes AM, Prudêncio M, Dechering KJ, Heussler VT, Pain A, Wilder BK, Roestenberg M, Janse CJ. Franke-Fayard B, et al. Among authors: wilder bk. NPJ Vaccines. 2022 Nov 4;7(1):139. doi: 10.1038/s41541-022-00558-x. NPJ Vaccines. 2022. PMID: 36333336 Free PMC article.
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine.
MacMillen Z, Hatzakis K, Simpson A, Shears M, Watson F, Erasmus J, Khandhar A, Wilder B, Murphy S, Reed S, Davie J, Avril M. MacMillen Z, et al. Among authors: wilder b. Res Sq [Preprint]. 2023 Jun 26:rs.3.rs-3045076. doi: 10.21203/rs.3.rs-3045076/v1. Res Sq. 2023. Update in: NPJ Vaccines. 2024 Jan 10;9(1):12. doi: 10.1038/s41541-023-00799-4 PMID: 37461621 Free PMC article. Updated. Preprint.
Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages.
Winnicki AC, King CL, Bosch J, Malachin AN, Carias LL, Skomorovska-Prokvolit Y, Tham WH, Dietrich MH, Popovici J, Roobsoong W, Beeson JG, Sattabongkot J, Yeoh LM, Opi DH, Feufack-Donfack LB, Orban A, Drago CL, McLaine OS, Redinger KR, Jung NC, Baldor L, Kirtley P, Neilsen K, Aleshnick M, Zanghi G, Rezakhani N, Vaughan AM, Wilder BK. Winnicki AC, et al. Among authors: wilder bk. bioRxiv [Preprint]. 2024 Aug 17:2024.02.07.579302. doi: 10.1101/2024.02.07.579302. bioRxiv. 2024. Update in: Nat Commun. 2024 Dec 4;15(1):10556. doi: 10.1038/s41467-024-53848-4 PMID: 38370683 Free PMC article. Updated. Preprint.
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Barrett JR, Pipini D, Wright ND, Cooper AJR, Gorini G, Quinkert D, Lias AM, Davies H, Rigby CA, Aleshnick M, Williams BG, Bradshaw WJ, Paterson NG, Martinson T, Kirtley P, Picard L, Wiggins CD, Donnellan FR, King LDW, Wang LT, Popplewell JF, Silk SE, de Ruiter Swain J, Skinner K, Kotraiah V, Noe AR, MacGill RS, King CR, Birkett AJ, Soisson LA, Minassian AM, Lauffenburger DA, Miura K, Long CA, Wilder BK, Koekemoer L, Tan J, Nielsen CM, McHugh K, Draper SJ. Barrett JR, et al. Among authors: wilder bk. Cell. 2024 Sep 5;187(18):4964-4980.e21. doi: 10.1016/j.cell.2024.06.015. Epub 2024 Jul 25. Cell. 2024. PMID: 39059380 Free article.
ELQ-331 as a prototype for extremely durable chemoprotection against malaria.
Smilkstein MJ, Pou S, Krollenbrock A, Bleyle LA, Dodean RA, Frueh L, Hinrichs DJ, Li Y, Martinson T, Munar MY, Winter RW, Bruzual I, Whiteside S, Nilsen A, Koop DR, Kelly JX, Kappe SHI, Wilder BK, Riscoe MK. Smilkstein MJ, et al. Malar J. 2019 Aug 27;18(1):291. doi: 10.1186/s12936-019-2921-9. Malar J. 2019. PMID: 31455339 Free PMC article.
282 results